Holy Stone Healthcare Co Ltd 4194
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- —
- Day Range
- —–—
- 52-Week Range
- —–—
- Bid/Ask
- — / —
- Market Cap
- —
- Volume/Avg
- — / —
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 8.80
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Holy Stone Healthcare Co Ltd is a Taiwan based company focused on a biopolymer drug delivery platform. It is involved in the development of new drugs and medical devices, especially hyaluronic acid related therapeutic products. The products of the company include RenehaVis, SportVis, TRUD, and GAF.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Value
- Total Number of Employees
- —
- Website
- http://www.hshc.com.tw
Comparables
Valuation
|
Metric
|
4194
|
6838
|
1701
|
|---|---|---|---|
Price/Earnings (Normalized) | — | — | 19.93 |
Price/Book Value | 22.53 | 6.33 | 0.88 |
Price/Sales | 8.80 | 214.54 | 0.76 |
Price/Cash Flow | — | — | 11.72 |
Price/Earnings
4194
6838
1701
Financial Strength
|
Metric
|
4194
|
6838
|
1701
|
|---|---|---|---|
Quick Ratio | 0.89 | 4.84 | 0.87 |
Current Ratio | 1.30 | 4.99 | 1.65 |
Interest Coverage | −408.91 | −71.54 | 7.38 |
Quick Ratio
4194
6838
1701
Profitability
|
Metric
|
4194
|
6838
|
1701
|
|---|---|---|---|
Return on Assets (Normalized) | −65.36% | −20.70% | 2.57% |
Return on Equity (Normalized) | −86.58% | −30.97% | 4.40% |
Return on Invested Capital (Normalized) | −76.74% | −30.85% | 3.43% |
Return on Assets
4194
6838
1701
Biotechnology Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
NVO
| Novo Nordisk A/S ADR | Zfbtmxvdb | Gsp | $554.7 Bil | |
VRTX
| Vertex Pharmaceuticals Inc | Cnzllhkk | Lzqvyr | $102.7 Bil | |
REGN
| Regeneron Pharmaceuticals Inc | Bvfsrppb | Yyvsmc | $97.8 Bil | |
MRNA
| Moderna Inc | Rxskfknww | Trsvt | $41.3 Bil | |
ARGX
| argenx SE ADR | Kmccfvgjv | Mwh | $22.3 Bil | |
BNTX
| BioNTech SE ADR | Dvtxbxgr | Mxpx | $21.0 Bil | |
ALNY
| Alnylam Pharmaceuticals Inc | Rccrkyw | Hkylcmw | $18.2 Bil | |
BMRN
| Biomarin Pharmaceutical Inc | Trxzjkcl | Drdgs | $15.4 Bil | |
RPRX
| Royalty Pharma PLC Class A | Xlxjwhpn | Tcswlp | $12.5 Bil | |
INCY
| Incyte Corp | Lxgkpkk | Pjynxpf | $11.6 Bil |